Ms Alison Kiley

KANDO id: 76859

Bio

Alison joined Alta Partners as an Associate in 2001 and became a Director of Alta Partners VIII in 2006. Her primary investment focus at Alta is on medical technology and biopharmaceuticals. She serves on the board of directors for Aegerion Pharmaceuticals, Esperion Therapeutics and Prolacta Bioscience. Alison also led Alta's investments in the original Esperion Therapeutics, Insulet Corporation, Kerberos Proximal Solutions and SurgRx. Prior to Alta, she was a Senior Associate in Robertson Stephens’ Life Sciences Investment Banking Group with primary responsibilities for the execution of corporate finance transactions including IPOs, follow-on equity and convertible preferred offerings. Previously, she was an Associate in Robertson Stephens’ Equity Research Group where she focused on growth medical technology companies. She began her career in the business development group at Geron, a biotechnology company. Alison earned a Master of Business Administration from Columbia Business School and a Bachelor of Arts in History from Colgate University.

Career


Alta Partners LP

Venture capital firm based in San Francisco which invests primarily in biotechnology and life science companies.
Director (past)

Education